• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺动脉高压中与右心室功能障碍相关的代谢改变:运动的调节作用及改善机制

Metabolic Alterations Associated With Right Ventricular Dysfunction in Pulmonary Arterial Hypertension: The Modulatory Effects and Improvement Mechanisms of Exercise.

作者信息

Chen Sitong, Liang Gengmin, Cheang Lokfai, Qu Qiang, Li Xinli

机构信息

State Key Laboratory for Innovation and Transformation of Luobing Theory, Department of Cardiology, The First Affiliated Hospital With Nanjing Medical University, 210029 Nanjing, Jiansgu, China.

出版信息

Rev Cardiovasc Med. 2025 Jul 30;26(7):37460. doi: 10.31083/RCM37460. eCollection 2025 Jul.

DOI:10.31083/RCM37460
PMID:40776975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12326408/
Abstract

Pulmonary arterial hypertension (PAH) is characterized by a significant increase in pulmonary arterial pressure, leading to right ventricular failure (RVF), limited exercise capacity, and increased mortality risk. Right ventricular function is a critical determinant of exercise capacity and prognosis in patients with PAH. Meanwhile, alterations in cellular metabolism and bioenergy are common features in PAH, with the differential regulation of metabolic pathways playing a significant role in right ventricular dysfunction (RVD). Mitochondria, essential organelles responsible for energy production, biosynthetic pathways, and signal transduction, are particularly implicated in differential regulation. Exercise is increasingly recognized as a beneficial adjunct therapy; however, specific recommendations are often lacking in official guidelines. This review examines the changes in metabolic pathways associated with RVD in PAH, including glycolysis, glucose oxidation, fatty acid oxidation, glutamine metabolism, and arginine metabolism. Furthermore, this article discusses how exercise can modulate the aforementioned metabolic pathways to improve metabolic disturbances in the right ventricle and enhance right heart function. These are essential for developing effective rehabilitation strategies.

摘要

肺动脉高压(PAH)的特征是肺动脉压力显著升高,导致右心室衰竭(RVF)、运动能力受限和死亡风险增加。右心室功能是PAH患者运动能力和预后的关键决定因素。同时,细胞代谢和生物能量的改变是PAH的常见特征,代谢途径的差异调节在右心室功能障碍(RVD)中起重要作用。线粒体作为负责能量产生、生物合成途径和信号转导的重要细胞器,尤其与差异调节有关。运动越来越被认为是一种有益的辅助治疗方法;然而,官方指南中往往缺乏具体建议。本综述探讨了PAH中与RVD相关的代谢途径变化,包括糖酵解、葡萄糖氧化、脂肪酸氧化、谷氨酰胺代谢和精氨酸代谢。此外,本文讨论了运动如何调节上述代谢途径,以改善右心室的代谢紊乱并增强右心功能。这些对于制定有效的康复策略至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec0/12326408/1a8d2b775e92/2153-8174-26-7-37460-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec0/12326408/1a8d2b775e92/2153-8174-26-7-37460-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec0/12326408/1a8d2b775e92/2153-8174-26-7-37460-g1.jpg

相似文献

1
Metabolic Alterations Associated With Right Ventricular Dysfunction in Pulmonary Arterial Hypertension: The Modulatory Effects and Improvement Mechanisms of Exercise.肺动脉高压中与右心室功能障碍相关的代谢改变:运动的调节作用及改善机制
Rev Cardiovasc Med. 2025 Jul 30;26(7):37460. doi: 10.31083/RCM37460. eCollection 2025 Jul.
2
Current landscape for connective tissue disease associated-pulmonary arterial hypertension: a focus on right ventricular adaptation and failure.结缔组织病相关肺动脉高压的现状:聚焦于右心室适应与衰竭
Future Cardiol. 2025 Aug;21(10):803-814. doi: 10.1080/14796678.2025.2529696. Epub 2025 Jul 11.
3
A multimodal approach identifies lactate as a central feature of right ventricular failure that is detectable in human plasma.一种多模态方法将乳酸鉴定为右心室衰竭的核心特征,这一特征在人体血浆中可检测到。
Front Med (Lausanne). 2024 Sep 12;11:1387195. doi: 10.3389/fmed.2024.1387195. eCollection 2024.
4
State of the Art in Pulmonary Arterial Hypertension: Molecular Basis, Imaging Modalities, and Right Heart Failure Treatment.肺动脉高压的最新进展:分子基础、成像方式及右心衰竭治疗
Biomedicines. 2025 Jul 20;13(7):1773. doi: 10.3390/biomedicines13071773.
5
Phosphodiesterase type 5 inhibitor plus endothelin receptor antagonist compared to either alone for group 1 pulmonary arterial hypertension.与单独使用相比,5型磷酸二酯酶抑制剂加内皮素受体拮抗剂用于1型肺动脉高压的治疗
Cochrane Database Syst Rev. 2025 Aug 4;8(8):CD015824. doi: 10.1002/14651858.CD015824.pub2.
6
Endothelin receptor antagonists for pulmonary arterial hypertension.用于治疗肺动脉高压的内皮素受体拮抗剂。
Cochrane Database Syst Rev. 2006 Jul 19(3):CD004434. doi: 10.1002/14651858.CD004434.pub3.
7
Inflammatory Glycoprotein 130 Signaling Links Changes in Microtubules and Junctophilin-2 to Altered Mitochondrial Metabolism and Right Ventricular Contractility.炎症糖蛋白 130 信号转导将微管和连接蛋白-2 的变化与改变的线粒体代谢和右心室收缩力联系起来。
Circ Heart Fail. 2022 Jan;15(1):e008574. doi: 10.1161/CIRCHEARTFAILURE.121.008574. Epub 2021 Dec 20.
8
Single-Cell and Spatial Transcriptomics Identified Fatty Acid-Binding Proteins Controlling Endothelial Glycolytic and Arterial Programming in Pulmonary Hypertension.单细胞和空间转录组学鉴定出控制肺动脉高压中内皮糖酵解和动脉编程的脂肪酸结合蛋白
Arterioscler Thromb Vasc Biol. 2025 May 22. doi: 10.1161/ATVBAHA.124.321173.
9
Sleep-Related Hypoxia, Right Ventricular Dysfunction, and Survival in Patients With Group 1 Pulmonary Arterial Hypertension.睡眠相关低氧、右心室功能障碍与 1 型肺动脉高压患者的生存
J Am Coll Cardiol. 2023 Nov 21;82(21):1989-2005. doi: 10.1016/j.jacc.2023.09.806.
10
Fatty acid metabolism promotes TRPV4 activity in lung microvascular endothelial cells in pulmonary arterial hypertension.脂肪酸代谢促进肺动脉高压肺微血管内皮细胞中 TRPV4 的活性。
Am J Physiol Lung Cell Mol Physiol. 2024 Mar 1;326(3):L252-L265. doi: 10.1152/ajplung.00199.2023. Epub 2024 Jan 16.

本文引用的文献

1
Combined exercise hinders the progression of pulmonary and right heart harmful remodeling in monocrotaline-induced pulmonary arterial hypertension.联合运动可阻碍野百合碱诱导的肺动脉高压中肺和右心有害重塑的进展。
J Appl Physiol (1985). 2025 Jan 1;138(1):182-194. doi: 10.1152/japplphysiol.00379.2024. Epub 2024 Nov 29.
2
Pathophysiology of the right ventricle and its pulmonary vascular interaction.右心室的病理生理学及其与肺血管的相互作用。
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01321-2024. Print 2024 Oct.
3
Poor cardiac output reserve in pulmonary arterial hypertension is associated with right ventricular stiffness and impaired interventricular dependence.
肺动脉高压时的心输出量储备不足与右心室僵硬度及心室间依赖受损有关。
Eur Respir J. 2024 Jul 18;64(1). doi: 10.1183/13993003.00420-2024. Print 2024 Jul.
4
(18)F-fluorodeoxyglucose uptake by positron emission tomography in patients with IPAH and CTEPH.特发性肺动脉高压和慢性血栓栓塞性肺动脉高压患者通过正电子发射断层扫描检测的(18)F-氟脱氧葡萄糖摄取情况
Pulm Circ. 2024 Apr 11;14(2):e12363. doi: 10.1002/pul2.12363. eCollection 2024 Apr.
5
Expression and regulation of HIF-1a in hypoxic pulmonary hypertension: Focus on pathological mechanism and Pharmacological Treatment.低氧性肺动脉高压中 HIF-1a 的表达与调控:关注病理机制与药物治疗。
Int J Med Sci. 2024 Jan 1;21(1):45-60. doi: 10.7150/ijms.88216. eCollection 2024.
6
Protective effect of Xinmai'an tablets via mediation of the AMPK/SIRT1/PGC-1α signaling pathway on myocardial ischemia-reperfusion injury in rats.心脉安片通过介导AMPK/SIRT1/PGC-1α信号通路对大鼠心肌缺血再灌注损伤的保护作用。
Phytomedicine. 2023 Nov;120:155034. doi: 10.1016/j.phymed.2023.155034. Epub 2023 Aug 16.
7
Metabolic reprogramming, oxidative stress, and pulmonary hypertension.代谢重编程、氧化应激与肺动脉高压。
Redox Biol. 2023 Aug;64:102797. doi: 10.1016/j.redox.2023.102797. Epub 2023 Jun 24.
8
Cardiac lipid metabolism, mitochondrial function, and heart failure.心脏脂质代谢、线粒体功能与心力衰竭。
Cardiovasc Res. 2023 Aug 19;119(10):1905-1914. doi: 10.1093/cvr/cvad100.
9
Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges.生理和病理性心肌肥厚中的代谢机制:新范例和挑战。
Nat Rev Cardiol. 2023 Dec;20(12):812-829. doi: 10.1038/s41569-023-00887-x. Epub 2023 May 26.
10
Metabolic profiling of in vivo right ventricular function and exercise performance in pulmonary arterial hypertension.肺动脉高压患者右心室功能和运动表现的代谢组学分析。
Am J Physiol Lung Cell Mol Physiol. 2023 Jun 1;324(6):L836-L848. doi: 10.1152/ajplung.00003.2023. Epub 2023 Apr 18.